News

Breast cancer survivors face a high risk of major depressive disorder, also known as clinical depression, particularly if they also have insomnia, according to findings from a new study of Kaiser Permanente members. “We determined that the risk of major depression disorder was markedly higher in breast cancer survivors than in a matched group of women ...

Nearly 1 in 5 urinary tract infections (UTIs) in Southern California could be due to E. coli strains transmitted through contaminated meat, according to a new study of Kaiser Permanente Southern California members. The research also found that those living in low-income neighborhoods were at increased risk of these infections. The study was published in mBio ...

After COVID-19 hit in 2020, some physicians within Kaiser Permanente grew concerned that their patients with diabetes weren’t achieving healthy blood sugar control. Even when they came into the office for a visit, follow-up for getting labs to check on their hemoglobin A1c— a blood test that measures the average blood sugar level over the ...

Adolescent and young adult cancer survivors face significantly higher risks of developing chronic medical conditions compared to their peers without cancer, a new study showed. The findings were published in Cancer, the journal of the American Cancer Society. “As cancer survival rates improve for adolescent and young adult cancer survivors, their numbers are increasing,” said the study’s ...

Sujatha Murali, MD, MS is a hematologist and medical oncologist in San Diego and currently serves as the Southern California Breast Cancer Lead and Principal Investigator for breast cancer clinical trials within Kaiser Permanente Southern California’s Cancer Clinical Trials Access Program. She joined Kaiser Permanente in 2016 after working at the Winship Cancer Institute of ...

After the Centers for Disease Control and Prevention issued opioid prescribing guidelines in 2016, the national opioid dispensing rates steadily declined. However, while reducing opioid prescriptions is critically important, abruptly stopping opioids for pain has been shown to possibly raise the risk of overdose for patients. Against this backdrop, Kaiser Permanente was among the first health ...

Talar Habeshian, PhD, MPH, was appointed as a postdoctoral research fellow in the Division of Epidemiologic Research at the Department of Research & Evaluation in August. She will focus on cancer research initiatives. Prior to her postdoctoral appointment, Dr. Habeshian worked as a research associate in the Division of Health Services Research & Implementation Science for ...

New Kaiser Permanente research shows that the COVID-19 vaccine does not increase the risk of developing tinnitus, which is a ringing in the ears. “Early on in the COVID-19 pandemic, some people complained about hearing some sound after being vaccinated, but it wasn’t actually an external sound, it was tinnitus, which is the perception of sound ...